Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease

Clinical trial NCT01747135 · COMPLETED

Trial details

NCT number: NCT01747135
Sponsor: Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Niemann-Pick Disease, Type C1

Start date: 2013-01-01
Primary completion: 2017-03-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.